MT1H and prostate cancer: Of specific note, by analyzing 30 sets of online microarray data, Han et al. [14] found a consistent downregulation of MT1H in various kinds of human malignancies as compared with normal tissues, including small cell lung cancer, neuroblastoma, melanoma, B-cell lymphoma, prostate cancer, colon cancer, breast cancer, and leukemia.